2006 Annual Meeting | Myasthenia Gravis: Diagnosis and Treatment

Date Sunday 04/02/06

Time 02:15 PM - 06:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type PM Half-Day Course

Director(s) Gil I. Wolfe, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should become familiar with the presentation, diagnostic evaluation, and management of patients with myasthenia gravis and related disorders, and learn to select therapies appropriate to the level of disease severity. Participants should also be able to recognize paraneoplastic issues related to disorders of neuromuscular transmission.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
02:15 PM - 03:00 PM		Diagnosis of Myasthenia Gravis Matthew N. Meriggioli, MD, FAAN
03:00 PM - 03:45 PM		Treatment of Myasthenia Gravis Gil I. Wolfe, MD, FAAN
03:45 PM - 04:00 PM		Break
04:00 PM - 04:50 PM		An Overview of Congenital Myasthenic Syndromes C. M. Harper, MD, FAAN
04:50 PM - 05:40 PM		Paraneoplastic Myasthenia and Related Neuromuscular Disorders Steven Vernino, MD, PhD, FAAN
05:40 PM - 06:00 PM		Questions and Answers

Faculty Disclosures
C. M. Harper, MD, FAAN	Dr. Harper has nothing to disclose.
Gil I. Wolfe, MD, FAAN	Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ArgenX. Dr. Wolfe has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB/Ra. Dr. Wolfe has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Cartesian. Dr. Wolfe has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grifols. The institution of Dr. Wolfe has received research support from UCB/Ra. The institution of Dr. Wolfe has received research support from Immunovant. The institution of Dr. Wolfe has received research support from Roche. Dr. Wolfe has received personal compensation in the range of $0-$499 for serving as a Advisor with FDA Advisory Panel for Cellular, Tissue and Genetic Therapies.
Matthew N. Meriggioli, MD, FAAN	Dr. Meriggioli has received personal compensation for serving as an employee of Novartis Gene Therapies. Dr. Meriggioli has received stock or an ownership interest from Novartis.
Steven Vernino, MD, PhD, FAAN	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for antag. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Dysautonomia International. Dr. Vernino has received personal compensation in the range of $10,000-$49,999 for serving as a Content Expert Consultant with Office of Inspector General for Medicare. Dr. Vernino has a non-compensated relationship as a Board of Directors with American Autonomic Society that is relevant to AAN interests or activities.

��ɫ��

��ɫ��